Comparison of Submucosal Dexamethasone and Methylprednisolone in Postoperative Sequelae of Parasymphsis Fractures
Recruiting now · Phase 2
Conditions studied: Mandible Fracture, Edema Face, Pain Management, Corticosteroid Injection
In brief
The rationale of the current research is to address the limitation of existing knowledge as it is not clear which of the two drugs (Dexamethasone or Methylprednisolone) is more effective in reduction of postoperative sequelae in patient with mandibular parasymphysis fracture. This study fills the gap by providing sound evidence on the preferred steroid option to help clinicians have more data to make decisions and improve patients' health. The result of this research will then be added to the evidence-based protocols for the treatment of parasymphysis fractures.
Key facts
- Study ID
- NCT07208799
- Run by
- Nishtar Medical University
- People needed
- 72
- Starts
- 2026-01-03
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2026-04-06
Who can join
Age: 18 and older, up to 40. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients aged 18 to 40.
- Both Gender.
- Fracture less than a week old.
- Isolated mandibular parasymphysis fractures.
You may not qualify if…
- 1. Immunocompromised patients (due to increased risk of infection and complications).
- Patients experiencing acute pain from conditions such as pulpitis, abscesses, or other acute infections (to ensure that acute pain does not confound the study results).
- Patients reporting hypersensitivity to steroids (to avoid adverse reactions).
- Patients taking or requiring prophylactic antibiotics or anti-inflammatory drugs before surgery (to prevent confounding effects on study outcomes).
- Patients with a history of systemic steroid administration for 15 days (as this could affect the study's outcomes).
- Patients with chronic pain problems or mental disorders (to maintain consistency in response to treatment).
- Patients with comminuted fractures (to maintain consistency in fracture type).
- Pregnant or lactating women (to avoid potential risks to the fetus and nursing infant).
- Smokers who smoke at least 10 cigarettes per day for 2 years (to minimize the impact of smoking on healing and recovery).
- ria:
Where it is running
- Nishtar Institute of Dentistry Multan — Multan, Punjab Province, Pakistan (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.